Roche competitorsClear all
Roche's top competitors include Amgen, Johnson & Johnson, Bayer, Abbott, Danaher, Pfizer, Becton Dickinson and Teva Pharmaceuticals.
| Save Comparison |  Roche Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Johnson & Johnson Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. |  Abbott Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines. |  Danaher Danaher is a company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. |  Pfizer Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products. |  Becton Dickinson Becton Dickinson is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. | ||
Founding Date | Founding Date 1896 | Founding Date 1980 | Founding Date 1886 | Founding Date 1863 | Founding Date 1888 | Founding Date 1984 | Founding Date 1849 | Founding Date 1897 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR Bella Vista, AU North Ryde, AU Sydney, AU Wien, AT see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Kew, AU North Ryde, AU Wien, AT Machelen, BE see more | Locations New Brunswick, US HQ Buenos Aires, AR Yerevan, AM Ultimo, AU Wien, AT Minsk, BY Beerse, BE see more | Locations Lake Bluff, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more | Locations Washington, US HQ Shanghai, CN Mumbai, IN New Delhi, IN Sunbury On Thames, GB | Locations Franklin Lakes, US HQ Vicente López, AR Macquarie Park, AU Schwechat, AT Wien, AT Aalst, BE Sao Paulo, BR see more | |||
Employees | Employees 97,7353% increase | Employees 23,4009% increase | Employees 132,2002% decrease | Employees 103,8241% decrease | Employees 107,0004% increase | Employees 60,00015% decrease | Employees 88,3004% decrease | Employees 70,0938% decrease | Employees 40,0396% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 144.7 b | Valuation ($) 383.5 b | Valuation ($) 61.3 b | Valuation ($) 183.2 b | Valuation ($) 148.8 b | Valuation ($) 200.3 b | Valuation ($) 65 b | Valuation ($) N/A |
Twitter followers | Twitter followers 219.7 k | Twitter followers 92.7 k | Twitter followers 203.9 k | Twitter followers 175.2 k | Twitter followers 103.9 k | Twitter followers N/A | Twitter followers 19.6 k | Twitter followers 10.1 k | Twitter followers 3.4 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 103 | Number of tweets (last 30 days) 87 | Number of tweets (last 30 days) 52 | Number of tweets (last 30 days) 47 | Number of tweets (last 30 days) 165 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 59 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 15.3 | Average likes per tweet (last 30 days) 19 | Average likes per tweet (last 30 days) 35.8 | Average likes per tweet (last 30 days) 7.2 | Average likes per tweet (last 30 days) 9.3 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 7.4 | Average likes per tweet (last 30 days) 5.6 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 97.09% | Percentage of tweets with engagement (last 30 days) 97.7% | Percentage of tweets with engagement (last 30 days) 86.54% | Percentage of tweets with engagement (last 30 days) 93.62% | Percentage of tweets with engagement (last 30 days) 53.94% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 93.22% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 65019 | Alexa Website Rank 185690 | Alexa Website Rank 24994 | Alexa Website Rank 81833 | Alexa Website Rank 37982 | Alexa Website Rank 121195 | Alexa Website Rank 75380 | Alexa Website Rank 90290 | Alexa Website Rank 357782 |
Employee Rating | Employee Rating N/A | Employee Rating 3.8 | Employee Rating 4.1 | Employee Rating N/A | Employee Rating 3.6 | Employee Rating 3.7 | Employee Rating 4.1 | Employee Rating 3.7 | Employee Rating 3.3 |
Financial | |||||||||
Revenue (est.) | Revenue (est.) CHF63.8b (FY, 2019) | Revenue (est.) $23.4b (FY, 2019) | Revenue (est.) $82.1b (FY, 2019) | Revenue (est.) €43.5b (FY, 2019) | Revenue (est.) $31.9b (FY, 2019) | Revenue (est.) $17.9b (FY, 2019) | Revenue (est.) $51.8b (FY, 2019) | Revenue (est.) $17.3b (FY, 2019) | Revenue (est.) $16.9b (FY, 2019) |
Cost of goods | Cost of goods CHF18.4b (FY, 2019) | Cost of goods $4.4b (FY, 2019) | Cost of goods $27.6b (FY, 2019) | Cost of goods €17.5b (FY, 2019) | Cost of goods $13.2b (FY, 2019) | Cost of goods $7.9b (FY, 2019) | Cost of goods $10.2b (FY, 2019) | Cost of goods $9b (FY, 2019) | Cost of goods $9.4b (FY, 2019) |
Gross profit | Gross profit CHF45.4b (FY, 2019) | Gross profit $19b (FY, 2019) | Gross profit $54.5b (FY, 2019) | Gross profit €26.1b (FY, 2019) | Gross profit $18.7b (FY, 2019) | Gross profit $10b (FY, 2019) | Gross profit $41.5b (FY, 2019) | Gross profit $8.3b (FY, 2019) | Gross profit $7.5b (FY, 2019) |
Net income | Net income CHF14.1b (FY, 2019) | Net income $7.8b (FY, 2019) | Net income $15.1b (FY, 2019) | Net income €2.4b (FY, 2019) | Net income $3.7b (FY, 2019) | Net income $3b (FY, 2019) | Net income $16.3b (FY, 2019) | Net income $1.2b (FY, 2019) | Net income ($999m) (FY, 2019) |
Operating ⚠ | |||||||||
Countries | Countries N/A | Countries 100 (FY, 2019) | Countries 60 (FY, 2018) | Countries 153 (FY, 2018) | Countries N/A | Countries 60 (FY, 2019) | Countries 125 (FY, 2017) | Countries N/A | Countries N/A |
Facilities | Facilities N/A | Facilities 190 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities N/A | Facilities 212 (FY, 2019) | Facilities N/A | Facilities 362 (FY, 2019) | Facilities N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 97 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 88 (FY, 2017) |
Manufacturing Sites | Manufacturing Sites 23 (FY, 2019) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 92 (FY, 2019) | Manufacturing Sites N/A | Manufacturing Sites 58 (FY, 2017) | Manufacturing Sites N/A | Manufacturing Sites N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2019) | Phase II Trials Products N/A | Phase II Trials Products 12 (Jan, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 14 (Feb, 2020) | Phase III Trials Products N/A | Phase III Trials Products 9 (Jan, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 29 (FY, 2017) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products 1.5 k (FY, 2019) | Products N/A | Products N/A | Products 86 k (FY, 2018) | Products N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers 3.5 k (Jun, 2018) | Suppliers 86.4 k (FY, 2019) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A |
Funding | |||||||||
Total funding raised | Total funding raised $ 2.8b | Total funding raised $ 175.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15m | Total funding raised $ 358m |
For sources of this data, please see the company profile
View company profiles
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View companyJohnson & Johnson
HQ
New Brunswick, US
Employees
132,200↓ 2% decrease
Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field.
View company
Bayer
HQ
Leverkusen, DE
Employees
103,824↓ 1% decrease
Bayer is a global life science company specializing in healthcare and nutrition.
View companyAbbott
HQ
Lake Bluff, US
Employees
107,000↑ 4% increase
Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines.
View company